What companies has Embryo Ventures invested in?

Embryo Ventures has invested in OSSTEC (3D-printed knee implants, medtech), BioLumen (sugar-elimination technology, food science), Pluvo (air purification systems), STAXY (mobility technology), Thermulon (silica aerogel insulation, construction), Calla Lily Clinical Care (women's health drug delivery), Gladys (AI-powered home care), Impli (real-time hormone monitoring), Bridgefy (Bluetooth mesh communication), Cheeky Panda (sustainable bamboo consumer goods), Laka (mobility and cycling insurance), and Taste Index (AI-powered taste management platform).

What sectors does Embryo Ventures focus on?

Embryo Ventures focuses on HealthTech, DeepTech, and Frontier technology. The portfolio spans medtech, health technology, clean technology, food science, mobility technology, insurtech, consumer goods, AI platforms, and communication infrastructure across healthcare, consumer, and industry verticals.

Where is Embryo Ventures based?

Embryo Ventures is based at 35 Berkeley Square, London, W1J 5BF. The fund is most active across the UK, Europe, and the United States, and backs startups globally.

How can I pitch Embryo Ventures?

Founders can pitch Embryo Ventures through their Typeform at embryoventureslondon.typeform.com. The fund evaluates pre-seed and seed stage companies across healthcare, consumer and industry — and is open to ideas beyond their listed focus areas.

Which UK VCs invest in medtech and healthtech startups?

Embryo Ventures, a London-based early-stage VC, actively invests in medtech and healthtech startups. Portfolio companies include OSSTEC (3D-printed bone implants, raised £2.5M in 2025 and expanding into the US market in 2026), Calla Lily Clinical Care (drug delivery collaboration with Merck, £1M NIHR funding for clinical trials), Gladys (AI home care, raised £1.5M), and Impli (real-time hormone monitoring, partnered with Bayer).

Which VCs back deep tech and clean technology startups in London?

Embryo Ventures is a London-based early-stage venture capital firm that backs deep tech startups including Thermulon (silica aerogel insulation for construction, founder Forbes 30 Under 30 2024), Pluvo (air purification systems trialled with Network Rail and South Western Railway), BioLumen (sugar-elimination food science technology), and Cheeky Panda (sustainable bamboo consumer goods, eight-figure turnover).

Which VCs invest in mobility, insurtech, and transport technology startups?

Embryo Ventures backs mobility and transport technology startups including STAXY (mobility platform used by Aston Villa Football Club for digital shuttle bus ticketing), Laka (specialist cycling and e-bike insurance, raised $10.4M Series B, partnered with Decathlon and Gazelle), and Bridgefy (Bluetooth mesh networking for off-line communication, partnered with Atlas Associates for Japanese municipalities).

Which VCs back consumer, food technology, and AI startups?

Embryo Ventures backs consumer and frontier technology startups including Cheeky Panda (sustainable bamboo tissue paper brand, partnered with NielsenIQ and HSBC), BioLumen (sugar-elimination technology, featured in Wall Street Journal and The Guardian, selected by PepsiCo for accelerator), and Taste Index (AI-powered taste management platform integrated by Roland Berger for food, retail, and FMCG companies).

News & Press

Portfolio developments &
media coverage

Q: What stage does Embryo Ventures invest at?

Embryo Ventures invests at pre-seed and seed stage. The firm is a long-term partner to visionary founders, providing early capital and support to bring bold visions to life, supporting startups to scale globally from initial seed funding through growth and international expansion.

Embryo Ventures is a London-based early-stage venture capital firm backing HealthTech, DeepTech, and Frontier technology startups across the UK, Europe, and globally. We are long-term partners to visionary founders at pre-seed and seed stages across healthcare, consumer and industry sectors, providing early capital and support to bring bold visions to life.

The following articles feature Embryo Ventures portfolio companies, including funding announcements, portfolio milestones, commercial partnerships, product launches, and global press coverage.

Last updated: 25 March 2026

Building something ambitious?

We partner with visionary founders building human-centric solutions across the UK, Europe, and globally. If you're working on something that should already exist, we want to hear about it.

Pitch Now ❯